XtalPi Holdings Ltd
2228
Kedudukan dalam Saham
#4646
XtalPi Holdings Limited functions as an investment holding company, delivering... XtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its comprehensive drug discovery services encompass the entire research and development process, ranging from target validation and hit identification to lead generation, lead optimization, and PCC nomination. These services are adept across diverse therapeutic modalities, such as small molecules, antibodies, peptides, ADCs, and PROTACs. The company's intelligent automation solutions specifically utilize artificial intelligence and automation to facilitate the accelerated discovery and research of novel drugs and materials. Established in 2015 and based in Shenzhen, China, the firm was formerly known as QuantumPharm Inc. before officially changing its name to XtalPi Holdings Limited in December 2024.
Harga Saham
$0.74616501
Modal Pasaran
$3.21B
Perubahan (1 hari)
-4.10%
Perubahan (1 tahun)
-50.36%
Negara
CN
Perdagangan XtalPi Holdings Ltd (2228)
Kategori
Healthcare
Pendapatan untuk XtalPi Holdings Ltd (2228)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini XtalPi Holdings Ltd, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi XtalPi Holdings Ltd dari 2024 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2025 | $18.85M | -109.08% |
| 2024 | $-207.54M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $5.27B | - |
US
|
|
| $-3.09B | - |
US
|
|
| $-4.02B | - |
AU
|
|
| $1.95B | - |
NL
|
|
| - | - |
CH
|
